Portfolio Update

Finsbury Worldwide Pharm Tst PLC
04 April 2005



                                                                    4 April 2005



                      FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC

                                    (the 'Company')


                           QUARTERLY STATEMENT OF INVESTMENTS





In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:



  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:


Company Name                                                        Value of Investment at      % of Total
                                                                                            Portfolio  Assets
                                                                        31 March 2005
Pfizer Com                                                                20,849,651               8.32
Genentech Inc                                                             17,068,930               6.81
Novartis                                                                  16,591,595               6.62
Altana AG                                                                 15,450,944               6.16
Amgen                                                                     13,092,321               5.22





  • The ten largest investments held by the Company comprise the following:


Company Name                                                         Value of Investment at      % of Total
                                                                                              Portfolio Assets
                                                                   31 March 2005

Pfizer Com                                                                 20,849,651               8.32
Genentech Inc                                                              17,068,930               6.81
Novartis                                                                   16,591,595               6.62
Altana AG                                                                  15,450,944               6.16
Amgen                                                                      13,092,321               5.22
Lilly (Eli) & Company                                                      11,575,783               4.62
Takeda Pharmaceutical                                                      10,976,609               4.38
Affymetrix Inc                                                             10,712,172               4.27
Genzyme Corp General Division                                              10,693,120               4.27
Serono SA 'B'                                                              10,028,637               4.00





                                    - ENDS -



For further information please contact:

Tracey Lago, Company Secretary

Close Finsbury Asset Management Limited

Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange